Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Polyethylene Glycol, 0.4%, Propylene Glycol, 0.3% eye drops
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 207
- Registration Number
- NCT02380248
- Locations
- 🇮🇳
Contact Alcon India for Trial Locations, Karnataka, India
A Clinical Study of Systane® Lid Wipes in Brazil
Not Applicable
Completed
- Conditions
- Skin ToleranceOcular Tolerance
- Interventions
- Other: Systane® Lid Wipes
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 35
- Registration Number
- NCT02380261
- Locations
- 🇧🇷
Novartis Biociencias SA, Sao Paulo, Brazil
Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Phase 3
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2015-01-15
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 493
- Registration Number
- NCT02339584
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion
Phase 4
Completed
- Conditions
- Vitreomacular AdhesionVitreomacular Traction
- Interventions
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 62
- Registration Number
- NCT02322229
- Locations
- 🇦🇺
Contact Alcon Laboratories (Australia) for Trial Locations, New South Wales, Australia
Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects
Phase 3
Completed
- Conditions
- Allergic Conjunctivitis
- Interventions
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 383
- Registration Number
- NCT02322216
Efficacy and Safety of RTH258 Versus Aflibercept - Study 1
Phase 3
Completed
- Conditions
- Neovascular Age-Related Macular DegenerationChoroidal Neovascularization
- Interventions
- First Posted Date
- 2014-12-04
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 1775
- Registration Number
- NCT02307682
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Formula Identification (FID) 114657 in Contact Lens Wearers
Not Applicable
Completed
- Conditions
- Refractive Error
- Interventions
- Drug: FID 114657 eye drops (10 ml)Drug: Saline control eye drops (15 ml)Device: Habitual contact lenses
- First Posted Date
- 2014-11-18
- Last Posted Date
- 2016-10-06
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 234
- Registration Number
- NCT02293538
Tear Film Evaluation of Dailies® AquaComfort Plus® Multifocal and Toric
Not Applicable
Completed
- Conditions
- Refractive Error
- Interventions
- Device: Nelfilcon A toric contact lensesDevice: Nelfilcon A multifocal contact lensesDevice: Nelfilcon A sphere contact lenses
- First Posted Date
- 2014-11-13
- Last Posted Date
- 2016-07-26
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 48
- Registration Number
- NCT02289742
A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema
Phase 1
Withdrawn
- Conditions
- Diabetic Macular Edema
- Interventions
- Biological: Sham injectionBiological: LKA651 ophthalmic solutionBiological: Ranibizumab ophthalmic solution
- First Posted Date
- 2014-11-02
- Last Posted Date
- 2015-12-11
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT02281292
DAILIES TOTAL1® Lens Centration in a Japanese Population
Not Applicable
Completed
- Conditions
- MyopiaRefractive Error
- Interventions
- Device: Delefilcon A contact lensesDevice: Narafilcon A contact lenses
- First Posted Date
- 2014-09-30
- Last Posted Date
- 2016-01-29
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 53
- Registration Number
- NCT02252133
- Locations
- 🇯🇵
Contact Alcon Japan Ltd. for Trial Locations, Tokyo, Japan
© Copyright 2025. All Rights Reserved by MedPath